Owl vs Fox.
Renalytics has failed. They had their test on the market years ago, it was priced at US$990.. they tried to do it themselves with their own sales team and Insurer teams. The test is not as good as PromarkerD and their shares have gone from £12 pounds to 50 pence.
They are being acquired for about AUD$ 90m for their technology alone.
The one thing I agree with you on is the very poor management of PIQ. Delay after delay.
The science is rock solid though.
Ann: PromarkerD US commercialisation & Promarker pipeline update, page-39
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
-0.020(2.06%) |
Mkt cap ! $124.4M | |||
| Open | High | Low | Value | Volume |
| 98.0¢ | 98.0¢ | 93.0¢ | $97.79K | 102.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2400 | 93.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 21799 | 3 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |